LeMaitre Vascular
LMAT
195 hedge funds and large institutions have $989M invested in LeMaitre Vascular in 2021 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 88 increasing their positions, 47 reducing their positions, and 13 closing their positions.
87% more repeat investments, than reductions
Existing positions increased: 88 | Existing positions reduced: 47
77% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 13
5% more funds holding
Funds holding: 185 → 195 (+10)
0.06% more ownership
Funds ownership: 85.93% → 85.99% (+0.06%)
8% less capital invested
Capital invested by funds: $1.08B → $989M (-$89.8M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
85% less call options, than puts
Call options by funds: $1.07M | Put options by funds: $6.99M
Top Buyers
| 1 |
BlackRock
New York
|
+$9.78M |
| 2 |
RIM
Ranger Investment Management
Dallas,
Texas
|
+$8.07M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.83M |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$4.07M |
| 5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$3.75M |
Top Sellers
| 1 |
Amundi
Paris,
France
|
-$6.15M |
| 2 |
TCM
Tygh Capital Management
Portland,
Oregon
|
-$4M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$3.98M |
| 4 |
State of New Jersey Common Pension Fund D
Trenton,
New Jersey
|
-$3.14M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$2.79M |
LMAT Hedge Fund Activity: Q3 2021 in Review
195 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in LeMaitre Vascular (LMAT) for Q3 2021, worth a combined $989M — down 8.3% from $1.08B a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new LMAT positions and 13 closed out — a net gain of 10 holders — while 88 added to existing stakes and 47 trimmed.
The largest buyer was BlackRock, adding an estimated $9.78M. The largest seller was Amundi, cutting an estimated $6.15M.
- 195 institutional investors held LeMaitre Vascular (LMAT) as of Q3 2021, up from 185 in Q2 2021.
- Funds reported $989M of LeMaitre Vascular stock for Q3 2021, down 8.3% quarter-over-quarter.
- 23 funds opened new LeMaitre Vascular positions in Q3 2021 and 13 closed out, a net change of +10 holders.
- The largest LeMaitre Vascular buyer in Q3 2021 was BlackRock, an estimated $9.78M added.
- The largest LeMaitre Vascular seller in Q3 2021 was Amundi, an estimated $6.15M sold.
Based on aggregated 13F filings for Q3 2021.